Evidence map›Paper›PMID 34837988›Full record

ArticleBMC public health2021

Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.

Hemant Kadiamada-Ibarra, Nicola L Hawley, Sandra G Sosa-Rubí, Marta Wilson-Barthes, Roxana Rodríguez Franco, Omar Galárraga

Erratum issued Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03674983 (PrEP Seguro), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03674983 nacompletednot on this map

PrEP Seguro: Antiretroviral-based HIV Prevention Among Men at High Risk in Mexico

TypeinterventionalSponsorBrown UniversityRan2019 to 2021Enrolled310ConditionsHIV InfectionsArmsConditional Economic Incentive (CEI)
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Incentivizing adherence to pre-exposure prophylaxis for HIV prevention: a randomized pilot trial among male sex workers in Mexico.The European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Hemant Kadiamada-IbarraBrown University School of Public Health, Providence, RI, 02912, USA.
Nicola L HawleyDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, 06510, USA.
Sandra G Sosa-RubíDivision of Health Economics, National Institute of Public Health (INSP), 62100, Cuernavaca, CP, Mexico.
Marta Wilson-BarthesDepartment of Epidemiology, Brown University School of Public Health, Providence, RI, 02912, USA.
Roxana Rodríguez FrancoCenter for Demographic, Urban, and Environmental Studies (CEDUA), The College of Mexico, 14110, Mexico City, CP, Mexico. roxrodriguez@colmex.mx.
Omar GalárragaDepartment of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, RI, 02912, USA.
Brown University · USCollege of Mexico · MXInstituto Nacional de Salud Pública · MXYale University · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
PrEP Seguro: Antiretrovial-based HIV prevention among men at high risk in MexicoR34MH114664 · NIMH · BROWN UNIVERSITY · PI GALARRAGA, OMAR · 2017 to 2019
$638k
NIAID NIH HHS P30 AI042853NIH HHS R34MH114664NIMH NIH HHS R34 MH114664Providence/Boston Center for AIDS Research 5P30AI042853
6 · The paper itself

Abstract

backgroundThe ImPrEP México demonstration project is the first to distribute free HIV pre-exposure prophylaxis (PrEP) to men who have sex with men (MSM) and transgender women living in Mexico. In Mexico City, MSM who are also male sex workers (MSWs) face a disproportionately high risk of HIV infection. PrEP is highly effective for HIV prevention, yet "real-life" implementation among MSWs is a challenge due to the unique adherence barriers faced by this population.

methodsThis study uses the RE-AIM implementation science framework to characterize the unique barriers to and facilitators of PrEP uptake among MSWs in Mexico City. We conducted 9 in-depth key informant interviews and 2 focus group discussions with MSWs across 5 clinic and community sites. Qualitative data were analyzed using inductive, open coding approaches from grounded theory. We supplemented findings from the primary qualitative analysis with quantitative indicators derived from ImPrEP program records to describe the current Reach of the ImPrEP program among MSWs in Mexico City and the potential for wider PrEP Adoption among other high-risk populations in Mexico.

resultsThe Reach of the ImPrEP program was 10% of known HIV-negative MSWs in Mexico City. Program Reach was lowest among MSWs who were street-based sex workers, of lower socioeconomic status, migrants from other states and self-identified as heterosexual. Barriers to program Reach included limited PrEP knowledge, HIV-related stigma, and structural barriers; facilitators included in-person program recruitment, patient-centered care, and spread of information through word of mouth among MSWs. Two out of the four eligible institutions had adopted the ImPrEP protocol. Barriers to wider program Adoption included HIV- and sexual identity- related stigma, protocol limitations, and lack of a national policy for PrEP distribution; facilitators of Adoption included existing healthcare infrastructure, sensitized providers, and community support from non-governmental organizations.

conclusionsIncreasing the ImPrEP program's Reach among MSWs will depend on improving PrEP education and addressing HIV-related stigma and access barriers. Future Adoption of the ImPrEP program should build on existing clinical infrastructure and community support. Creation of a national policy for PrEP distribution may improve the Reach and Adoption of PrEP among highest-risk populations in Mexico.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesSex WorkersCommunity SupportFemaleHomosexuality, MaleHumansMaleMexicoAnti-HIV AgentsMale sex workersMen who have sex with menMexicoPre-exposure prophylaxisRE-AIM

Identifiers

PMID34837988
PMCPMC8626882
OpenAlexW3217201711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.